Cargando…

Defects in Glutathione System in an Animal Model of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progredient neurodegenerative disease characterized by a degeneration of the first and second motor neurons. Elevated levels of reactive oxygen species (ROS) and decreased levels of glutathione, which are important defense mechanisms against ROS, have been re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wunsch, Franziska T., Metzler-Nolte, Nils, Theiss, Carsten, Matschke, Veronika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215445/ https://www.ncbi.nlm.nih.gov/pubmed/37237880 http://dx.doi.org/10.3390/antiox12051014

Ejemplares similares

Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis
por: Klatt, Christina L., et al.
Publicado: (2019)

Increased ROS-Dependent Fission of Mitochondria Causes Abnormal Morphology of the Cell Powerhouses in a Murine Model of Amyotrophic Lateral Sclerosis
por: Stein, Jan, et al.
Publicado: (2021)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis
por: Cha, Sun Joo, et al.
Publicado: (2020)

Animal models of amyotrophic lateral sclerosis: a comparison of model validity
por: Morrice, Jessica R., et al.
Publicado: (2018)

Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
por: Traiffort, Elisabeth, et al.
Publicado: (2021)

The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
por: Vanneste, Joni, et al.
Publicado: (2021)

Melittin Ameliorates the Inflammation of Organs in an Amyotrophic Lateral Sclerosis Animal Model
por: Lee, Sun-Hwa, et al.
Publicado: (2014)

Oxidative stress: the lowest common denominator of multiple diseases
por: Matschke, Veronika, et al.
Publicado: (2019)

Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis
por: Kim, Kiyoung
Publicado: (2021)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Anti-Inflammatory Effect of Gamisoyo-San in an Animal Model of Amyotrophic Lateral Sclerosis
por: Park, Sunjung, et al.
Publicado: (2018)

Anti-Neuroinflammatory Effect of Jaeumganghwa-Tang in an Animal Model of Amyotrophic Lateral Sclerosis
por: Lee, Sun Hwa, et al.
Publicado: (2019)

Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model
por: Cai, Mudan, et al.
Publicado: (2019)

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
por: Maksimovic, Katarina, et al.
Publicado: (2023)

Memory-guided navigation in amyotrophic lateral sclerosis
por: Maier, Patrizia M., et al.
Publicado: (2023)

DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis
por: Konopka, Anna, et al.
Publicado: (2022)

Molecular Chaperones’ Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis
por: Kinger, Sumit, et al.
Publicado: (2023)

The Peripheral Immune System and Amyotrophic Lateral Sclerosis
por: McCombe, Pamela A., et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis as a Systemic Disease
por: Moresi, Viviana
Publicado: (2023)

Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2011)

The interaction of genetics and environmental toxicants in amyotrophic lateral sclerosis: results from animal models
por: Sher, Roger B.
Publicado: (2017)

MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
por: Martinez, Bridget, et al.
Publicado: (2021)

Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
por: Zhu, Longhong, et al.
Publicado: (2023)

Genetic Rodent Models of Amyotrophic Lateral Sclerosis
por: Van Den Bosch, L.
Publicado: (2011)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Where and Why Modeling Amyotrophic Lateral Sclerosis
por: Liguori, Francesco, et al.
Publicado: (2021)

Staging model for amyotrophic lateral sclerosis in Singapore
por: Tay, Yuan Teck, et al.
Publicado: (2021)

Caffeine and NAD(+) Improve Motor Neural Integrity of Dissociated Wobbler Cells In Vitro
por: Zwilling, Mareike, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

An Intercellular Flow of Glutathione Regulated by Interleukin 6 Links Astrocytes and the Liver in the Pathophysiology of Amyotrophic Lateral Sclerosis
por: López-Blanch, Rafael, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Defective Mitochondrial Dynamics Is an Early Event in Skeletal Muscle of an Amyotrophic Lateral Sclerosis Mouse Model
por: Luo, Guo, et al.
Publicado: (2013)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eokvna2hureldaje1dnfli96ij